SGTX NASDAQ
Sigilon Therapeutics, Inc.
1W: +0.0%
1M: +5.0%
3M: +200.4%
1Y: +152.2%
$22.47
Last traded 2023-08-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$18M
Revenue
+76.8% YoY
$-30M
Net Income
+55.5% YoY
$-33M
Free Cash Flow
+55.8% YoY
100.0%
Gross Margin
-126.0%
Op. Margin
-127.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-74.6%
ROA-36.3%
ROIC37476.4%
Valuation
P/E-16.8
P/B18.6
EV/EBITDA-27.7
Leverage
Debt/Equity0.27
Current Ratio1.78
Interest Cov.-12.9x
Quality Scores
Piotroski F3/9
Altman Z7.83
Beneish M132.00